Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials

Safety of Selegiline Transdermal System in Clinical Practice

(2012) Chi-Un Pae et al.   JOURNAL OF CLINICAL PSYCHIATRY

Selegiline transdermal system in major depressive disorder

(2012) Ashwin A Patkar et al.   Neuropsychiatry

Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?

(2011) Bradley N. Gaynes et al.   DEPRESSION AND ANXIETY

St. John’s wort extract LI160 for the treatment of depression with atypical features – A double-blind, randomized, and placebo-controlled trial

(2010) Marcus Mannel et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Atypical Depression

(2009) Chi-Un Pae et al.   CNS DRUGS

Do atypical features affect outcome in depressed outpatients treated with citalopram?

(2009) Jonathan W. Stewart et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets

(2009) Ohidul Siddiqui et al.   Journal of Biopharmaceutical Statistics

HPA axis and sleep: Identifying subtypes of major depression

(2008) Irina Antonijevic et al.   STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS